About Us
1919
Established
October 12
Milestones
¥1,010.7bn
Consolidated Revenue
March 2026
Company Outline
100
Diseases or Conditions Treated
*As of April 2026
Facts & Figures
40
Countries or Regions
*As of March 2026
Worldwide Office Locations
News
- Oct. 13, 2026 CorporateOlympus Receives FDA Warning Letter
- Aug. 17, 2026 CorporateOlympus Announces Global Distribution Agreement with Endocision for Respiratory Cryobiopsy System
- Aug. 07, 2026 CorporateOlympus Reports First Quarter Fiscal 2027 Financial Results
- May. 04, 2026 CorporateOlympus Signs Global Distribution Agreement with EndoRobotics, Adds Robot-Assisted Technologies to EndoTherapy Portfolio
- Mar. 02, 2026 CorporateSharing the Importance of Screening Through the Experience of a Colorectal Cancer Survivor — A “True to Life” Story








